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Abstract
Regular nut consumption is associated with lower adiposity and reduced weight gain in adulthood. 
Walnut feeding studies have observed minimal effect on body weight despite potential additional 
energy intake. Several mechanisms may explain why consuming nuts promotes weight control, 
including increased early phase satiety, possibly reflected in postprandial response of 
gastrointestinal and pancreatic peptides hypothesized to affect appetite. The purpose of this study 
was to compare postprandial insulin, glucagon and gastrointestinal peptide response and satiety 
following a meal with ~54% of energy from walnuts or cream cheese, using a within-subject 
crossover study design in overweight/obese adults (N = 28). Sixty minutes after the walnut-
containing meal, glucagon-like peptide-1 was lower than after the reference meal (p=0.0433), and 
peptide YY, cholecystokinin and ghrelin did not differ after the two meals. Sixty and 120 min after 
the walnut-containing meal, pancreatic polypeptide (p = 0.0014 and p = 0.0002) and glucose-
dependent insulinotropic peptide (p < 0.0001 and p = 0.0079) were lower than after the reference 
meal, and 120 min after the walnut-containing meal, glucagon was higher (p=0.0069). Insulin and 
C-peptide increased at 60 min in response to both meals but were lower at 120 min after the 
walnut-containing meal (p=0.0349 and 0.0237, respectively). Satiety measures were similar after 
both meals. These findings fail to support the hypothesis that acute postprandial gastrointestinal 
peptide response to a walnut-containing meal contributes to increased satiety. However, inclusion 
of walnuts attenuated the postprandial insulin response, which may contribute to the more 
favorable lipid profile observed in association with regular walnut consumption.
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1. Introduction
Although energy intake compared to expenditure is the ultimate determinate of weight loss 
or weight gain, dietary strategies are sorely needed to facilitate a sustained reduction in 
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energy intake that promotes weight management and/or weight reduction for overweight and 
obese individuals. Gastrointestinal peptides hypothesized to affect appetite potentially 
contribute to the control of food intake by affecting appetite and early phase satiety, and they 
exhibit differential responses to various dietary strategies such as modified diet composition 
and food form (Delzenne et al., 2010; Sobrino Crespo, Perianes Cachero, Puebla Jimenez, 
Barrios, & Arilla Ferreiro, 2014). Exploring these responses to foods and dietary factors 
may provide insight and help to identify useful dietary strategies to promote long-term 
weight management.
Regular consumption of nuts has been negatively associated with adiposity in several large 
cohorts (Mattes & Dreher, 2010; Mattes, Kris-Etherton, & Foster, 2008; Natoli & McCoy, 
2007). For example, women in the Nurses’ Health Study who reported eating nuts ≥2 times/
week had less weight gain and lower risk of obesity than did women who rarely ate nuts 
when followed prospectively (Bes-Rastrollo et al., 2009). In an analysis that combined three 
separate cohorts of men and women who were followed for nearly 20 years, intake of nuts 
was one lifestyle and dietary factor found to be inversely associated with weight gain in 
adulthood (Mozaffarian, Hao, Rimm, Willett, & Hu, 2011). The PREDIMED trial examined 
the effect of three dietary interventions on risk for cardiovascular disease outcomes, one of 
which involved supplementation of the diet with nuts, and changes in body weight did not 
differ across diet groups but participants assigned to supplemental nut consumption showed 
a significant decrease in central obesity (Babio et al., 2014).
The specific effects of consuming various nuts in a weight loss intervention have been 
examined in a few studies and have had mixed results (Abazarfard, Salehi, & Keshavarzi, 
2014, pp. 457–64; Foster et al., 2012; Li et al., 2010; Pelkman et al., 2004; Wien, Sabate, 
Ikle, Cole, & Kandeel, 2003). In a recent randomized clinical trial, we observed that 
prescribing walnuts, despite their high energy density, was associated with weight loss 
comparable to a standard lower fat diet, and better than a higher fat, lower carbohydrate diet 
without walnuts, in the context of reduced energy intake and a behavioral weight loss 
program (Rock et al., 2016).
Several mechanisms have been suggested to explain why consuming energy-dense nuts is 
generally not associated with weight gain and may facilitate weight management (Mattes et 
al., 2008; Natoli & McCoy, 2007). Nuts may promote satiety, which could modulate appetite 
and promote dietary compensation; e.g., total energy intake may be spontaneously reduced 
due to greater satiety and satiation association with nut consumption. Also, recent evidence 
using modern methods has revealed that walnuts contribute less metabolizable energy in 
humans than is calculated by proximate analysis and standardized Atwater estimates (Baer, 
Gebauer, & Novotny, 2016). Further, walnuts are rich in polyunsaturated fatty acids (PUFA), 
which are associated with higher postprandial thermogenesis compared to meals high in 
saturated fat (Casas-Agustench et al., 2009) and may also influence the satiety response 
(Kozimor, Chang, & Cooper, 2013). Satiety is potentially reflected in the postprandial 
response of the gastrointestinal peptides hypothesized to be involved in the control of satiety 
and appetite (Delzenne et al., 2010). Feelings of satiety, fullness, and hunger following 
walnut consumption has been examined in only two previous studies (Brennan, Sweeney, 
Liu, & Mantzoros, 2010; Casas-Agustench et al., 2009), and the postprandial gastrointestinal 
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peptides response following walnut consumption has been examined in only one of these 
studies (Brennan et al., 2010).
The purpose of this study was to compare postprandial insulin, glucagon and gastrointestinal 
peptide response and satiety following a meal with or without walnuts, using a within-
subject crossover study design in overweight/obese adults (N = 28). We also examined self-
reported satiety following these meals using a visual analog scale.
2. Methods
2.1. Subjects
Subjects were non-diabetic overweight and obese men and women (N = 28) who met the 
following inclusion criteria: Aged 21 years and older, body mass index (BMI) ≥27.0 kg/m2 
and ≤40 kg/m2; non-smoker; willing and able to participate in clinic visits and telephone and 
Internet communications; willing to allow blood collections; and with no known allergy to 
tree nuts. Prior to enrollment, subjects were screened for diabetes and considered ineligible 
with a fasting blood glucose ≥125 mg/dL. The UCSD institutional review board approved 
the study protocol, and all participants provided written informed consent.
2.2. Study design and protocol
This study was a within-subject crossover study design. Demographic data were collected 
and height and weight of participants were measured during screening, and BMI was 
calculated as kg/m2. All subjects completed two meal feeding clinic visits one week apart, at 
which the subject consumed, in randomized order, either a breakfast meal containing 
walnuts or a meal without walnuts (the reference meal). Participants were instructed to eat 
their regular dinner prior to the day of the meal feeding clinic visit and fast for at least 12 h 
prior to their visit time. They were asked to eat a similar dinner meal for both days prior to 
the clinic-based test meals. Liquids consumed with the meal (e.g., water, tea, coffee) were 
monitored to ensure equivalent intake during the two meals. Participants were instructed to 
consume the test meal within 20 min and were monitored and observed to adhere to this 
protocol.
The energy content of the test meal was individualized to contain approximately 30% of 
total energy requirements estimated using the Harris Benedict equation (Frankenfield, Muth, 
& Rowe, 1998) and ranged from 400 to 600 kilocalories. Table 1 shows the nutrient content 
of the 500 kcal meal, and amounts of the food items were adjusted accordingly to meet the 
other energy levels. Macronutrient distribution of the test meal was matched at each energy 
level. Fiber content was similar although slightly higher in the walnut-containing meal 
compared to the reference meal (i.e., 8.8 g versus 6.0 g in the 500 kcal meal). Although total 
fat content was similar in the two meals, saturated fat was higher in the reference meal 
because walnuts contain substantial amounts of PUFA (47% of the fat grams) and 
monounsaturated fatty acids (MUFA, 9% of the fat grams). All test meals were prepared by 
the same investigative team on the morning of each of the study days.
At each of the two meal feeding clinic visits, fasting blood specimens were collected from 
each subject before the meal, and additional blood specimens were provided at 30, 60, and 
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120 min after the meal. BD-P800 tubes (BD, Franklin Lakes, NJ, USA) containing protease, 
esterase, and DPP-IV inhibitors were used for collecting the blood used in the analysis of 
gut hormones. After blood collection and separation, plasma aliquots were stored at −80° C 
in cryogenic tubes until analysis.
3. Measurements
3.1. Laboratory measures
The MILLIPLEX MAP Human Gut Hormone Panel (EMD Millipore, Merck KGaA, 
Darmstadt, Germany) was used for the simultaneous quantification of the following 
analytes: glucagon-like peptide-1 (GLP-1) (active), ghrelin (active), pancreatic polypeptide 
(PP), glucose-dependent insulinotropic peptide (GIP), peptide YY (PYY) (total), C-peptide, 
insulin, and glucagon. Cholesystokinin (CCK) was measured using the ELISA RayBio 
Human CCK EIA kit (Ray Biotech, Norcross, GA, USA).
3.2. Visual analog scale (VAS)
Concurrent with each of the four blood draws at each meal visit, subjects were asked to rate 
their satiety by answering three questions on a visual analog scale (VAS). Each of the 
questions was presented to the participant on a computer screen within a REDCap (Research 
Electronic Data Capture, Vanderbilt University, Nashville, TN, USA) database, with a 100 
mm horizontal line anchored at either end, so that answers could be indicated on a 
continuous scale. This general approach has been shown to have validity, reliability, and 
reproducibility (Gibbons, Finlayson, Dalton, Caudwell, & Blundell, 2014). The questions 
were: “How hungry do you feel?” with anchor values ranging from “I am not hungry at all” 
(scored as 0) to “I have never been more hungry” (scored as 100); “How full do you feel?”, 
with anchor values ranging from “Not at all full” (scored as 0) to “Totally full” (scored as 
100), and “How much do you think you could eat now?” with anchor values ranging from 
“Nothing at all” (scored as 0) to “A lot” (scored as 100). We also constructed a satiety index 
using the mean of the three satiety questions, where hunger and “how much could you eat” 
were scored inversely (100 – VAS value).
3.3. Power calculation and statistical analysis
Our analysis plan noted that a sample size of 20 subjects in a crossover design was adequate 
to distinguish between changes in both PYY and GIP after a walnut-containing meal 
compared to a placebo test meal (Brennan et al., 2010). This sample size did not provide 
power to distinguish differential responses for insulin, active ghrelin, or GLP-1.
Statistical analysis was conducted using a repeated measures mixed model for each analyte, 
assuming unstructured covariance. Main effects in each model were time (before eating time 
0, and 30, 60, and 120 min after eating) and meal type (reference being the cream cheese-
containing reference meal and the experimental meal containing walnuts). The interaction 
between meal and time was also included as a predictor of outcome in each model. Each 
multivariate model tested the hypothesis that the responses did not vary by diet over time, 
and we present the global F statistic and significance for each analyte. In addition, we tested 
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the significance of the meal × time interaction at each distinct time point using an analysis of 
least squares mean difference within each mixed model.
As an exploratory analysis, baseline peptide levels were compared by sex and BMI to 
explore whether there were any differences based on those characteristics. The analysis for 
sex used independent t tests, and the analysis for BMI used linear regression analysis. In 
order to better understand the benefit of tailoring meals to the participant’s energy 
requirements, we did an additional exploratory analysis in which we split our sample of 28 
subjects into 14 subjects with a BMI <33 kg/m2, and 14 subjects with BMI >33 kg/m2, and 
tested for a difference in effect size of two selected analytes (insulin and C-peptide) at 60 
and 120 min after eating.
We employed a Bonferroni correction for the 9 peptides and set alpha for type 1 error at 
0.0056. All analysis was done with SAS version 9.4 (SAS Institute, Cary, NC, USA).
4. Results
Study participant characteristics are presented in Table 2. Self-reported satiety measures 
(feelings of hunger, fullness and anticipated prospective consumption) obtained with the 
VAS were similar in response to the two meals. The calculated satiety index also did not 
differ between the two meals at the baseline and follow-up time points (Fig. 1 and Table 3).
Prior to the meals, gut peptide levels did not differ by meal assignment. Men had higher 
insulin and C-peptide levels than women at baseline: insulin mean [SEM] 19 [1.6] μU/mL 
for men and 13 [1.1] μU/mL for women, p = 0.0048; C-peptide mean [SEM] 1898 (144) 
pg/mL versus 1493 (82) pg/mL (p = 0.0116). Men had lower levels of ghrelin than women 
(20 [4] pg/mL versus 48 [6]) pg/mL, p = 0.0033). Glucagon also was higher in men than 
women (52 [5] pg/mL versus 35 [6] pg/mL, p = 0.0468). The other analytes did not differ by 
sex. The only two analytes which were found to be associated with BMI, both directly, were 
insulin (p = 0.0353), and C-peptide (p = 0.0016). Based on analysis using a median split of 
BMI, BMI does not appear to modify effect size for either analyte at 60 and 120 min after 
eating.
Measured levels of ghrelin (active), CCK, GLP-1 (active), and PYY (total) are shown in Fig. 
2 and Table 3. The only meal-related difference was observed at 60 min, where GLP-1 was 
lower after the walnut-containing meal. Postprandial PYY, ghrelin, and CCK did not differ 
between the meals at any of the time points (Fig. 2 and Table 3).
At 120 min after the walnut-containing meal, glucagon was higher than the reference meal, p 
= 0.0069 (Fig. 3 and Table 3). Insulin and C-peptide levels increased at 60 min in response 
to both meals but were lower at 120 min after the walnut-containing meal (p = 0.0349 and p 
= 0.0237 respectively). Additional postprandial peptide responses are shown in Table 4. At 
30 min after the meal, the walnut-containing meal resulted in marginally lower levels of PP 
compared with the reference meal (p = 0.0499). At both 60 and 120 min after eating the 
walnut-containing meal, subjects had significantly lower levels of PP (p = 0.0014 and p = 
0.0002) and GIP (p < 0.0001 and p = 0.0079) than they did after eating the reference meal.
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Among the global models for each analyte, the models for GIP, C-peptide, and glucagon met 
the Bonferroni threshold for significance (p < 0.0056). Notably, the Bonferroni correction 
assumes independence of the analytes. Given the intercorrelation of some of our measures 
(e.g., GLP-1 and glucagon rho = 0.64, C-peptide and insulin rho = 0.85, C-peptide and GIP, 
rho = 0.57), the Bonferroni correction is likely to be unduly stringent.
5. Discussion
Results from this study suggest that acute effects of walnut consumption on postprandial 
gastrointestinal peptides do not explain the favorable effect of consuming nuts on weight 
management, at least in the phase of early satiety. These peptides have been hypothesized to 
contribute to satiety and the control of appetite and may be potential biomarkers, but 
assessing and interpreting these levels is complicated by the effects of variations in timing of 
their response and other influencing factors, such as habituation to meal patterns, food form, 
and degree of adiposity (Delzenne et al., 2010). Further, their relationship with satiety is not 
yet clear, with the lack of a correlation that has been observed between these peptides and 
self-reported satiety and satiation in many studies (Delzenne et al., 2010; Steinert et al., 
2017). As recently reviewed by (Steinert et al., 2017), it remains unclear whether these 
gastrointestinal peptides have a physiological endocrine function that contributes to the 
control of eating.
We did observe an effect of walnut consumption on postprandial insulin, C-peptide and 
glucagon response, despite the similar energy and macronutrient contents of the meals. In 
many feeding studies, walnuts have been shown to lower low-density lipoprotein cholesterol 
and triglyceride levels (Kris-Etherton, 2014). Higher fasting and postprandial insulin levels, 
as occurs in association with insulin resistance, promotes increased fatty acid synthesis, 
elevated fasting triglyceride levels, and decreased high-density lipoprotein cholesterol 
(HDL-C) levels (Klop, Elte, Cabezas, 2013; Reaven, 2012). We found the beneficial effects 
of a walnut-rich diet on lipids, especially HDL-C and triglycerides, were especially 
pronounced for insulin resistant women (Le et al., 2016). Results from this study may be 
compared to two previous studies in which satiety following a walnut-containing meal was 
compared to that following a reference meal without walnuts. The acute effects of three 
high-fat meals on energy expenditure, substrate oxidation and satiety were compared in the 
study by Casas-Agustench et al. (2009), using a crossover trial design and VAS measure 
similar to the present study. Healthy men (N = 29) consumed three isocaloric meals: high in 
PUFA from walnuts (approximately 47 g walnuts), MUFA, or saturated fatty acids (SFA). 
The meal high in PUFA from walnuts was associated with similar satiety measures at 30, 90, 
210 and 300 min postprandially, as compared to a meal high in MUFA from olive oil or a 
meal high in SFA from dairy products, which is in agreement with the findings of the 
present study.
In another study involving a sample of men and women with the metabolic syndrome (N = 
63), a similar crossover design was used to examine the effect of a walnut-containing meal 
(48 g walnuts) or placebo, provided in a blenderized liquid formulation, on satiety and 
postprandial gut hormones and insulin measured daily over a four-day period (Brennan et 
al., 2010). On the first and last day of each visit, subjects had a fasting blood draw and 
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repeated blood samples collected every 30 min for 3 h following consumption of the liquid 
meal. Fullness, satiety, and hunger were assessed by a VAS before breakfast and lunch on 
each day of both visits. An increased sense of satiety and fullness were found on days 3 and 
4 following the walnut-containing meal. Similar to the results of the present study, few 
differences in the postprandial peptide responses were observed. However, GIP levels were 
lower on days 1 and 4 following the walnut-containing meal than the reference meal as seen 
in the present study. Postprandial insulin was similar in response to the two meals in that 
study, unlike our observation, but the sample populations differed considerably in the two 
studies (theirs consisted entirely of individuals with metabolic syndrome, with higher levels 
of fasting insulin and insulin resistance).
This study has several strengths. One strength is the comparability of the two meals with 
regard to nutrient content, other than that due to the inclusion of walnuts in the test meal, 
which resulted in a substantial difference in the proportion of PUFA in that meal. In a 
previous study, PYY and satiety response (assessed via VAS similar to the present study) 
was compared over a 5-h period in a crossover design to PUFA-rich, MUFA-rich, and SFA-
rich meals (Kozimor et al., 2013). The PUFA source in the meal in that study was sunflower 
oil and flaxseed oil, rather than walnuts, as in the present study. They found that the 
postprandial PYY response was lower for the MUFA-rich meal versus the SFA-rich or 
PUFA-rich meals, and the SFA-rich meal promoted greater subjective feels of fullness 
compared to the MUFA-rich or PUFA-rich meals.
A limitation of this study is that the postprandial blood samples were collected at specific 
intervals, and as previously noted, the timing and trajectory of the gut peptide response can 
vary considerably, so that maximal response may be missed without continuous measures. 
Even follow-up measures more frequent or over a longer time span than in the present study 
are at high risk of not capturing peak responses, affecting accurate interpretation of the 
response (Delzenne et al., 2010). Another limitation of this study is that the focus was on 
short-term, acute responses and early phase satiety, and measuring responses over the long-
term would better model the observational studies relating nut consumption to adiposity and 
weight management. We assessed response to individual meals rather than assessing satiety 
over days or weeks of food intake. Notably, the degree of control and standardization that 
are ideal, as well as considerations of subject burden, make the application of this type of 
design and comparison difficult over long periods of time. Also, there are very few previous 
studies of the effect of nut consumption on gastrointestinal peptide response, which 
constrain estimating adequate sample size to achieve statistical power to detect differences.
In conclusion, these findings fail to support the hypothesis that acute postprandial 
gastrointestinal peptide response to a walnut-containing meal contribute to increased satiety 
after walnut consumption. However, the inclusion of walnuts in the meal attenuated the 
postprandial insulin response, which may contribute to the more favorable lipid profile that 
has been observed in association with regular walnut consumption.
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Fig. 1. 
Satiety measures after experimental (walnut) or reference (control) breakfast. Questions 
were “How hungry do you feel” (“Hungry”), “How full do you feel” (“Full”), “How much 
do you think you could eat” (“Quant”). Satiety index (“Satiety”) is aggregated among the 
three questions on a 100-point scale. “Exp” denotes experimental meal, and “Ref” denotes 
reference meal.
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Fig. 2. 
Ghrelin, cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide YY after 
experimental (walnut) or reference (control) breakfast. “Exp” denotes experimental meal, 
and “Ref” denotes reference meal.
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Fig. 3. 
Insulin (bars) and glucagon (lines) after experimental (walnut) or reference (control) 
breakfast. “Exp” denotes experimental meal, and “Ref” denotes reference meal. Values 
shown are means and standard errors. Glucagon response was different by meal type, p = 
0.0031.
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Table 2
Subject characteristics (total N = 28; n = 19 female, n = 9 male).
Mean (SD) Range
Age (yrs) 49.1 (11.1) 39–67
Height (m) 1.66 (0.11) 1.47–1.84
Weight (kg) 91.8 (15.2) 69.7–132.3
BMI (kg/m2) 32.9 (2.8) 27.6–39.4
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